"Portugal Pharmaceuticals & Healthcare Report Q1 2016" now available at Fast Market Research

Fiscal loosening by the newly-initiated Socialist-led government in Portugal and rising private consumption will benefit pharmaceutical sales in 2016. According to the latest data on market activity we have revised upwards our pharmaceutical market forecast, although operating challenges will remain due to high levels of debt in the public hospital sector. Meanwhile, with competitiveness to diminish due to the partial reversal of austerity measures, we do not see major room for Portuguese industrial sectors to become more attractive to investors in the near term, including the pharmaceutical sector. That said, long-term demand for healthcare due to an ageing population will keep translating in to the need for access to medical treatment, supporting market growth over the forecast period.

Full Report Details at
- http://www.fastmr.com/prod/1109922_portugal_pharmaceuticals.aspx?afid=301

Headline Expenditure Projections

Pharmaceuticals: EUR3.43bn (USD4.59bn) in 2014 to EUR3.44bn (USD3.78bn) in 2015; 0.3% in local currency and -17.7% in US dollar terms. Forecast revised upwards from last quarter in local currency terms and US dollar terms.
Healthcare: EUR16.07bn (USD21.53bn) in 2014 to EUR15.82bn (USD17.41bn) in 2015; 0.3% in local currency and -17.7% in US dollar terms. Forecast revised downwards from last quarter in local currency terms and US dollar terms.

The Portugal Pharmaceuticals & Healthcare Report features BMI Research's forecasts for drugs and healthcare expenditure and imports and exports, focusing on the growth outlook for the prescription, OTC, patented drugs and generics market segments.

BMI's Portugal Pharmaceuticals & Healthcare Report provides industry professionals, strategists, company executives, investors, analysts and sales/marketing heads with independent forecasts and competitive intelligence on the Portugal pharmaceutical and healthcare industry.

Key Benefits

* Benchmark BMI's pharmaceutical and healthcare market forecasts for Portugal, to test other views - a key input for successful budgeting and strategic business planning in the Portuguese pharmaceutical and healthcare market.
* Target business opportunities and risks in the Portuguese pharmaceutical and healthcare sector through our reviews of latest industry trends, regulatory changes and major deals, projects and investments in Portugal.
* Assess the activities, strategy and market position of your competitors using our company profiles (including SWOTs, KPIs and latest activity) and competitive landscape tables.

Coverage

BMI Industry View



About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156 (1.413.485.7001 Int'l)

You may also be interested in these related reports:

- France Pharmaceuticals & Healthcare Report Q1 2016
- Saudi Arabia Pharmaceuticals & Healthcare Report Q1 2016
- Kenya Pharmaceuticals & Healthcare Report Q1 2016
- Ukraine Pharmaceuticals & Healthcare Report Q1 2016
- Thailand Pharmaceuticals & Healthcare Report Q1 2016